Key facts
- This page summarizes David I. Sandoval's Form 4 filing for MAXCYTE, INC. (MXCT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2025, 18:47.
David I. Sandoval - 18 Mar 2025 Form 4 Insider Report for MAXCYTE, INC. (MXCT)
- Reporting relationship
- GENERAL COUNSEL
- Issuer ticker
- MXCT
- Reported as of
- 18 Mar 2025
- Net transaction value
- -$1,122
- SEC form
- 4
- Accepted by SEC
- 20 Mar 2025, 18:47:50 UTC
- Prior SEC filing
- 18 Mar 2025
- Next SEC filing
- 23 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Sandoval
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David I. Sandoval filed Form 4 for MAXCYTE, INC. (MXCT) on 20 Mar 2025.
Change
- Previous filing in this sequence was filed on 18 Mar 2025.
- Current net transaction value: -$1,122.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MXCT
transaction
Common Stock
Sale
- Transaction value
- $1,122
- Shares
- -353
- Change %
- -0.55%
- Price
- $3.18
- Shares after
- 64,219
- Date
- 18 Mar 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were sold to cover tax withholding due upon vesting of previously granted restricted stock units ("RSUs"). Such "sale to cover" was automatically effected to satisfy tax withholding obligations and does not represent a discretionary trade by the Reporting Person.
Footnote F2
The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $3.14 to $3.215, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.